April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Associations Between Aspirin Use and Aging Macula Disorder. The Eureye Study
Author Affiliations & Notes
  • P. T. V. M. de Jong
    Ophthalmogenetics, NIN/Genetics, Amsterdam, The Netherlands
  • U. Chakravarthy
    Ophthalmology, Queens University of Belfast, Belfast, United Kingdom
  • M. Rahu
    Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia
  • J. Seland
    Stavanger Univ Hospital, Univ of Bergen, Bergen, Norway
  • G. Soubrane
    Ophthalmology, Creteil Eye Clinic Univ Hospital, Creteil, France
  • F. Topouzis
    Ophthalmology, Aristotle Univ of Thessaloniki, Thessaloniki, Greece
  • J. R. Vingerling
    Ophthalmology/Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
  • J. Vioque
    Dept Salud Publica, Univ Miguel Hernandez, Alicante, Spain
  • A. E. Fletcher
    Epidemiology & Population Health, London Sch of Hygiene & Trop Med, London, United Kingdom
  • EUREYE Study Group
    Ophthalmogenetics, NIN/Genetics, Amsterdam, The Netherlands
  • Footnotes
    Commercial Relationships  P.T.V.M. de Jong, None; U. Chakravarthy, None; M. Rahu, None; J. Seland, None; G. Soubrane, None; F. Topouzis, None; J.R. Vingerling, None; J. Vioque, None; A.E. Fletcher, None.
  • Footnotes
    Support  European Commission Vth framework (QLK6-CT-1999-02094); Macular Disease Society UK.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1620. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. T. V. M. de Jong, U. Chakravarthy, M. Rahu, J. Seland, G. Soubrane, F. Topouzis, J. R. Vingerling, J. Vioque, A. E. Fletcher, EUREYE Study Group; Associations Between Aspirin Use and Aging Macula Disorder. The Eureye Study. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1620.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To disentangle the conflicting evidence on associations between aspirin use and aging macula disorder (AMD), similar to age-related macular degeneration.

Methods: : Population-based, cross-sectional EUREYE study in seven centers from North to South Europe. Intake of any dose of aspirin and possible risk factors for AMD were ascertained by a structured questionnaire. Ophthalmic and basic systemic measurements were performed in a standardized way. Early AMD, subdivided in grades 1-3, and late AMD, subdivided as neovascular AMD or geographic atrophy, were graded on digitized fundus images by experienced graders in one center. Associations were analyzed by logistic regression with adjustment for potential confounders as age, systolic blood pressure, BMI, cholesterol level, sex, and history of alcohol consumption, angina, cardiovascular disease (CVD), diabetes mellitus, education level, intake of other pain killers, and smoking.

Results: : Of 4691 participants aged 65 or over, 36.4% had early AMD and 3.3% late AMD. Monthly use of any aspirin was reported by 41.2%, at least once a week by 7% and daily use by 17.3%. Odds ratios for grade 1 early AMD rose with increasing aspirin intake frequency till 1.26 (95% confidence interval (CI) 1.08-1.46; p trend < 0.001) for daily users; similarly for grade 2 early AMD till 1.40 (95%CI 1.16-1.68; p trend < 0.001) and for neovascular AMD till 2.26 (95%CI 1.66-3.08; p trend < 0.001) after full adjustment, including for CVD. There was no interaction between aspirin use and angina or CVD. No association was found with geographic atrophy.

Conclusions: : Frequent aspirin use seems to be harmful for AMD in older populations. Future case-control studies, cohort studies or randomized trials might further elucidate the magnitude of these associations.

Keywords: age-related macular degeneration • drug toxicity/drug effects 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.